Search - tctmd.com

Displaying 121 - 140 of 485

Sort: Relevancy | Date

Presentation TCT 2017

Importance of Implantation Technique and Evidence for "PSP " From Real-world and Registry Data

Presenter: Nick E. J. West, Joanna J. Wykrzykowska, Salvatore Brugaletta

November 01, 2017

Presentation TCT 2017

Featured Lecture: Discerning the Causes of BRS Failure - Insights From a Consensus Meeting and Literature Review

Presenter: Nick E. J. West, Joanna J. Wykrzykowska, Juan F. Granada

November 01, 2017

Presentation TCT 2017

Insights into Asymmetric Scaffold Bioreabsorption and Failure Mechanism

Presenter: Nick E. J. West, Joanna J. Wykrzykowska, Elazer R. Edelman

November 01, 2017

Presentation TCT 2017

BRS Benchtop Findings: Implications for Implantation Technique

Presenter: Nick E. J. West, Joanna J. Wykrzykowska, Yoshinobu Onuma

November 01, 2017

Presentation TCT 2017

Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples)

Presenter: Gregg W. Stone, Peter H. Stone, Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Flash Debate: Bioresorbable Scaffolds Are Appropriate for Clinical Use in Suitable Patients With Optimal Technique!

Presenter: Sanjay Kaul, Tullio Palmerini, Robert-Jan van Geuns

November 01, 2017

Presentation TCT 2017

Flash Debate: Bioresorbable Scaffolds Should Rarely be Used Outside of Carefully Controlled Research Studies!

Presenter: Sanjay Kaul, Tullio Palmerini, Robert A. Byrne

November 01, 2017

Presentation TCT 2017

The PLLA-Based Xinsorb

Presenter: Ron Waksman, Robert-Jan van Geuns, Junbo Ge

October 31, 2017

Presentation TCT 2017

The Thin-Strut PLLA-Based Arteriosorb

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2017

Presentation TCT 2017

The RENUVIA PLLA-Based BRS Platform With Extended Drug Release

Presenter: Ron Waksman, Robert-Jan van Geuns, Sujith K Seneviratne

October 31, 2017

Presentation TCT 2017

The Thin-Strut PLLA-Based FIRESORB

Presenter: Ron Waksman, Robert-Jan van Geuns, Bo Xu

October 31, 2017

Presentation TCT 2017

Mirage: Imaging and Clinical Outcomes With a Circular PLLA Microfiber-Derived BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2017

Presentation TCT 2017

Left Main Case(s) #7: Rationale and Feasibility of Bioresorbable Scaffolds

Presenter: Kenneth Chin, Nicholas J. Lembo, Bernardo Cortese

October 31, 2017

Presentation TCT 2017

The Thin-Strut PLLA-Based MeRes100

Presenter: Ron Waksman, Robert-Jan van Geuns, Ashok Seth

October 31, 2017

Presentation TCT 2017

The Sirolimus-Eluting PLLA-Based Neovas Scaffold: Extended Results From the Randomized Trial

Presenter: Bernard R. Chevalier, Corrado Tamburino, Kai Xu

October 31, 2017

Presentation TCT 2017

Magmaris: Clinical and Imaging Results With Drug-Eluting Magnesium-Based Scaffolds

Presenter: Bernard R. Chevalier, Corrado Tamburino, Ron Waksman

October 31, 2017

Presentation TCT 2017

Fortitude, Aptitude, and Magnitude: Progressively Thin-Strut BRS Based on Ultra-High Molecular Weight Amorphous PLLA

Presenter: Bernard R. Chevalier, Corrado Tamburino, Juan F. Granada

October 31, 2017

Presentation TCT 2017

Fantom: A Radio-Opaque Stent-Like BRS With Improved Expansion Characteristics

Presenter: Bernard R. Chevalier, Corrado Tamburino, James B. Hermiller Jr.

October 31, 2017

Presentation TCT 2017

Desolve Nx, Cx, and Amity: A Family of Progressively Thinner-Strut PLLA-Based BRS With Novel Properties

Presenter: Bernard R. Chevalier, Corrado Tamburino, Stefan Verheye

October 31, 2017

Presentation TCT 2017

Do Some, All, or None of the Outcomes With the First Generation Absorb Scaffold Imply a Class Effect for All BRS? Educated Insights

Presenter: Bernard R. Chevalier, Corrado Tamburino, Yoshinobu Onuma

October 31, 2017

Advertisement

Importance of Implantation Technique and Evidence for "PSP " From Real-world and Registry Data

Featured Lecture: Discerning the Causes of BRS Failure - Insights From a Consensus Meeting and Literature Review

Insights into Asymmetric Scaffold Bioreabsorption and Failure Mechanism

BRS Benchtop Findings: Implications for Implantation Technique

Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples)

Flash Debate: Bioresorbable Scaffolds Are Appropriate for Clinical Use in Suitable Patients With Optimal Technique!

Flash Debate: Bioresorbable Scaffolds Should Rarely be Used Outside of Carefully Controlled Research Studies!

The PLLA-Based Xinsorb

The Thin-Strut PLLA-Based Arteriosorb

The RENUVIA PLLA-Based BRS Platform With Extended Drug Release

The Thin-Strut PLLA-Based FIRESORB

Mirage: Imaging and Clinical Outcomes With a Circular PLLA Microfiber-Derived BRS

Left Main Case(s) #7: Rationale and Feasibility of Bioresorbable Scaffolds

The Thin-Strut PLLA-Based MeRes100

The Sirolimus-Eluting PLLA-Based Neovas Scaffold: Extended Results From the Randomized Trial

Magmaris: Clinical and Imaging Results With Drug-Eluting Magnesium-Based Scaffolds

Fortitude, Aptitude, and Magnitude: Progressively Thin-Strut BRS Based on Ultra-High Molecular Weight Amorphous PLLA

Fantom: A Radio-Opaque Stent-Like BRS With Improved Expansion Characteristics

Desolve Nx, Cx, and Amity: A Family of Progressively Thinner-Strut PLLA-Based BRS With Novel Properties

Do Some, All, or None of the Outcomes With the First Generation Absorb Scaffold Imply a Class Effect for All BRS? Educated Insights

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content